帕斯坦(奧沙拉秦鈉)
...]及其緩解期的長期維持治療。[用法與用量]開始劑量爲lgdˉ1,分次口服,以後逐漸增至3gdˉ1,分34次服用。兒童劑量爲20?40mgkgˉ1?dˉ1。長期維持治療時成人劑量爲0.5gdˉl,分2次服用。本品應在進餐時伴服。[藥物不良反應]常見腹瀉...
藥品天地;專業藥學;藥學研究帕斯坦(奧沙拉秦鈉)
...]及其緩解期的長期維持治療。[用法與用量]開始劑量爲lgdˉ1,分次口服,以後逐漸增至3gdˉ1,分34次服用。兒童劑量爲20?40mgkgˉ1?dˉ1。長期維持治療時成人劑量爲0.5gdˉl,分2次服用。本品應在進餐時伴服。[藥物不良反應]常見腹瀉...
藥品天地;專業藥學;新藥櫥窗河南食管癌高發區ABO血型及血細胞分類記數與食管癌和賁門癌關係研究
...tinSCCthanthatinGCA.ConclusionThepresentresultsindicatethatSCCoccursmorefreˉquentlyinpatientswithBbloodtype,GCAseemstooccurmorefrequentlyinmalewithObloodtypeandBbloodtypeinfemale.AnemiaandlymphcelldecreasingareverycommoninGCA,anditsclinicalsignificanceneedstobefurthercharˉacterized. Keywo...
資料庫;在線期刊;中華現代內科學雜誌;2004年第1卷第2期焦慮相關人格特質與5-羥色胺轉運體基因多態性的研究
...atedhealthyHanChineseindividuals.GenotypeweredeteminedbyPCR.Anassociationbeˉtweenthetwopolymorphismtraitswasstudiedinaampleof148healthyHanChinesesubjects.Results(1)For5-HTTLPR,ICofthispolymorphismwas0.352.For5-HTTStin2,PICofthispolymorphismwas0.153.Significantdifˉferencesintheallelefrequen...
合作平臺;在線期刊;中華醫學實踐雜誌;2004年第3卷第12期;論著維奧欣對血管性疾呆的臨牀療效及作用機制研究
...iningthelevelofET-1andOxLDL.MethodsFollowingPortera-sancheymethod,50vascuˉlardementiapatientsweredividedintotreatmentgroup(30cases)andcontrolgroup(20cases).ThecontrolgroupreˉceivedNaofukanganagement,andthetreatmentgroupreceivedWeiaoxinmanagement.Beforeandaftertreatment,allpatientswer...
合作平臺;在線期刊;中華現代中西醫雜誌;2004年第2卷第11期;論著妊娠期糖尿病合併妊娠高血壓綜合徵婦女的糖代謝特點與胰島素抵抗特徵
...oevaluatecharacteristicsofcarbohydratemetabolismandinsulinresistanceingraviˉdaswiththecoexistenceofgestationaldiabetesmellitus(GDM)andpregnancy-inducedhypertension(PIH)Synˉdrome(PIH).MethodsFifty-eigtywomeninlatepregnancywereobserved,twelvewomenwithGDMandpregnancy-inducedhypertonsion...
合作平臺;在線期刊;中華現代中西醫雜誌;2004年第2卷第5期;論著曲美他嗪在2型糖尿病並穩定型心絞痛患者中的療效評價
...Toassesstheanti-anginalefficacyoftrimetazidine(TMZ)incombinationwithconˉventionaltreatmentintype2diabeticpatientswithstableanginapectoris.MethodsSixty-seventype2diabeticpaˉtientswithstableanginapectoriswereincluded,thendividedintotwogroups:onegroupwasgivenTMZ20mgtidcomˉbinedwiththreetraditi...
合作平臺;在線期刊;中華實用醫藥雜誌;2004年第4卷第16期;論著腎移植受者血中PBMCs的基因表達譜分析
...alyzethedifferentialexpressionofthegenesinthePBMCsofthepatientshavingacceptˉedrenaltransplantation.The30patientshavingacceptedrenaltransplantation(4weeksafteroperation)werecollectˉedfreshbloodaccordingtopreoperation(ascontrolgroup)andpostoperation4weeks(aspostoperationgroup).ByFiˉcoll...
合作平臺;在線期刊;中華醫藥雜誌;2004年第4卷第8期;論著微粒化非諾貝特對2型糖尿病患者血脂及血管內皮功能的影響
...ithfenofibrate,TGlevelwassignificantlydecreasedby40.2%andHDL-Clevelwassigˉnificantlyincreasedby29.8%.Comparedbeforetreatment(4.21±1.62%)andafter12weekstreatmentwithplacebo(5.64±1.58%),FMDwassignificantlyincreased(7.66±1.35%,P0.01)After12weekstreatmentwithfenofibrate.NTG-MDwassi...
合作平臺;在線期刊;中華現代中西醫雜誌;2004年第2卷第12期;論著影響子宮內膜癌遠期療效的因素分析
...eToanalyzetheinfluencefactorsoflongtermsresultsforendometrialcarcinoma.MethˉodsFromJanuary1984toJune1994,therewere74endometrialcarcinomacases,13instageIa,36instageIb,9instageIc,10instageⅡ,5instageⅢ.Therewere50caseswhounderwentthesurgeryonly,andtheother24casesunˉderwentthecombined...
合作平臺;在線期刊;中華現代臨牀醫學雜誌;2004年第2卷第4B期